A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

The Stratus COVID-19 variant, which includes the XFG and XFG.3 strains, currently accounts for around 30 per cent of COVID-19 ...

Patients with bronchiectasis face heightened risks of severe exacerbation and mortality after COVID-19 recovery, especially ...

Encounter-level factors played a key role in limiting outpatient COVID-19 treatment for Black and Latino patients.

Sarilumab and tocilizumab are equally effective in reducing organ support duration and death in patients who are critically ill with COVID-19.

Because COVID-19 is caused by a virus, antibiotics cannot be used to treat it. However, Pulia says physicians may feel they ...

An expert group charged by the World Health Organization to investigate the origins of the COVID-19 pandemic has found no ...